SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001140361-21-026244
Filing Date
2021-07-30
Accepted
2021-07-30 16:38:14
Documents
13
Period of Report
2021-04-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A brhc10027417_8ka.htm   iXBRL 8-K/A 151918
2 EXHIBIT 99.5 brhc10027417_ex99-5.htm EX-99.5 18059
  Complete submission text file 0001140361-21-026244.txt   334073

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlry-20210428.xsd EX-101.SCH 3917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlry-20210428_lab.xml EX-101.LAB 23242
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlry-20210428_pre.xml EX-101.PRE 16526
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10027417_8ka_htm.xml XML 4389
Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray, Inc. (Filer) CIK: 0001731348 (see all company filings)

IRS No.: 824310622 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38594 | Film No.: 211133132
SIC: 2833 Medicinal Chemicals & Botanical Products